9 Meters Biopharma Inc
(NMTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,624 | 29,659 | 15,861 | 29,456 | 37,242 |
| TOTAL | $9,197 | $33,018 | $18,454 | $31,348 | $39,088 |
| Non-Current Assets | |||||
| PPE Net | 9 | 10 | 13 | 15 | 17 |
| Other Non-Current Assets | 107 | 120 | 23,669 | 146 | 159 |
| TOTAL | $116 | $130 | $23,682 | $160 | $177 |
| Total Assets | $9,313 | $33,148 | $42,135 | $31,509 | $39,264 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,231 | 5,053 | 1,438 | 2,326 | 1,912 |
| Accrued Expenses | 5,758 | 4,380 | 6,774 | 6,956 | 6,256 |
| Other current liabilities | 454 | 1,585 | 1,945 | N/A | N/A |
| TOTAL | $15,578 | $30,696 | $12,863 | $9,340 | $8,224 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 15,744 | N/A | N/A |
| Other Non-Current Liabilities | 35 | 51 | 68 | 83 | 98 |
| TOTAL | $35 | $51 | $15,812 | $83 | $98 |
| Total Liabilities | $15,612 | $30,747 | $28,674 | $9,423 | $8,323 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,460 | 14,336 | 12,955 | 12,955 | 12,955 |
| Common Shares | 1 | 1 | 1 | 26 | 26 |
| Retained earnings | -226,476 | -212,607 | -200,677 | -191,323 | -180,192 |
| TOTAL | $-6,299 | $2,401 | $13,461 | $22,086 | $30,942 |
| Total Liabilities And Equity | $9,313 | $33,148 | $42,135 | $31,509 | $39,264 |